Ms. magazine  -- more than a magazine a movement

SIGN UP FOR MS. DIGEST, JOBS, NEWS AND ALERTS

FEMINIST WIRE NEWSBRIEFS

ABOUT
SEE CURRENT ISSUE
SHOP MS. STORE
MS. IN THE CLASSROOM
FEMINIST DAILY WIRE
FEMINIST RESOURCES
PRESS
JOBS AT MS.
READ BACK ISSUES
CONTACT
RSS (XML)
 
feminist wire | daily newsbriefs

March-24-09

Court Rules that FDA Reconsider Restrictions on Sale of Plan B

Edward Korman, a New York District Court Judge ruled yesterday that the FDA must reconsider its 2006 ruling that allowed emergency contraception (EC), also known as Plan B, to be sold without a prescription to women 18 and older. The ruling (see PDF) also specifically orders Barr Pharmaceuticals, which distributes Plan B, to make EC available over-the-counter to women as young as 17 within 30 days.

Emergency contraception is effective up to five days (120 hours) after unprotected sex, birth control failure, or rape, but it is most effective (95 percent) if taken within 24 hours. Because of the time-sensitive nature of EC, over-the-counter access is crucial to its effective use.

In the ruling, Korman wrote: "These political considerations, delays, and implausible justifications for decision-making are not the only evidence of a lack of good faith and reasoned agency decision-making. Indeed, the record is clear that the FDA's course of conduct regarding Plan B departed in significant ways from the agency's normal procedures regarding similar applications to switch a drug product from prescription to non-prescription use, referred to as a 'switch application' or an 'over-the-counter switch'. the matter is remanded to the FDA for reconsideration of whether to approve Plan B for over-the counter status without age or point-of-sale restrictions. While the FDA is free, on remand, to exercise its expertise and discretion regarding the proper disposition of the Citizen Petition, no useful purpose would be served by continuing to deprive 17 year olds access to Plan B without a prescription."

A recent study found that access to EC has improved since the 2006 ruling by the FDA allowing the morning after pill to be sold without a prescription to women 18 and older. The FDA approved over-the-counter sales of EC after a massive campaign, during which the Feminist Majority Foundation sent tens of thousands of petitions to the FDA asking for approval of EC over-the-counter.

Media Resources: Feminist Daily Newswire 8/24/06, 12/8/08; United States District Court Eastern District of New York 3/23/09


© Feminist Majority Foundation, publisher of Ms. magazine

If you liked this story, consider making a tax-deductible donation to support Ms. magazine.

 

 

Send to a Friend
Their
Your
Comments
(optional)


More Feminist News

4/17/2015 Senate Passes Compromise Bill Increasing Federal Funding for Abstinence-Only Sex Education - The Senate overwhelmingly approved of HR 2 on Tuesday, a $200 billion package that included an enormous increase of federal funding for abstinence-only-until-marriage (AOUM) curricula. The US Senate voted 92-8 to pass HR 2, which has been known as the "doc fix" for Medicaid reimbursement rates, as well as many other health care provisions. . . .
 
4/16/2015 March2Justice Protesters Embark on 250-Mile March to Protest Police Brutality - Marchers are ending an eight-day journey across 250 miles and five states to deliver anti-profiling and police-force-militarization legislation from New York City to Washington, D.C. . . .
 
4/16/2015 One Year Since the Kidnappings, #BringBackOurGirls Still Matters - In April of 2014, almost 300 Nigerian schoolgirls were kidnapped by the terrorist group Boko Haram. . . .